EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Advancing CNS tumor diagnostics with expanded DNA methylation-based classification

Martin Sill, Daniel Schrimpf, Areeba Patel, Dominik Sturm, Natalie Jäger, Philipp Sievers, Leonille Schweizer, Rouzbeh Banan, David Reuss, Abigail Suwala, Andrey Korshunov, Damian Stichel und 48 weitere

Cancer Cell · 2026-02 · 44 (2) · 340-354.e2

DOI: 10.1016/j.ccell.2025.11.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Cell, 2026-02. Verfasst von Martin Sill und 59 weiteren Autor:innen. Beteiligte Einrichtung: Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and G…. Hauptthemen laut MEDLINE: DNA Methylation, Central Nervous System Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 60-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute of Neurological Disorders and Stroke, National Cancer Institute, Deutsche Kinderkrebsstiftung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

DNA methylation-based classification is now central to contemporary neuro-oncology, as highlighted by the World Health Organization (WHO) classification of central nervous system (CNS) tumors. We present the Heidelberg CNS Tumor Methylation Classifier version 12.8 (v12.8), trained on 7,495 methylation profiles, which expands recognized entities from 91 classes in version 11 (v11) to 184 subclasses. This expansion is a result of newly identified tumor types discovered through our large online repository and global collaborations, underscoring CNS tumor heterogeneity. The random forest-based classifier achieves 95% subclass-level accuracy, with its well-calibrated probabilistic scores providing a reliable measure of confidence for each classification. Its hierarchical output structure enables interpretation across subclass, class, family, and superfamily levels, thereby supporting clinical decisions at multiple granularities. Comparative analyses demonstrate that v12.8 surpasses previous versions and conventional WHO-based approaches. These advances highlight the improved precision and practical utility of the updated classifier in personalized neuro-oncology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA MethylationCentral Nervous System NeoplasmsBiomarkers, TumorHumans

Stichwörter der Autor:innen

CNS tumorsDNA methylationMLOpsartificial intelligenceclassificationepigeneticsmachine learningmolecular diagnosticsprecision medicinetumor heterogeneity

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany. Electronic addres…
  • Department of Neuropathology, University Hospital Heidelberg, Heidelberg, Germany; Clinical Cooperation Unit Neuropathology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKF…
  • Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany; Department of Neuropathology, University Hospital Heidelberg, Heidelberg, Germany; Clinical Cooperation Unit Neuropathology, German Consortium for Tr…
  • Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany; Division of Pediatric Glioma Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Institute of Neurology (Edinger Institute), University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany; German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, German Cancer Research Center (DKF…

Förderung

  • National Institute of Neurological Disorders and Stroke
  • National Cancer Institute
  • Deutsche Kinderkrebsstiftung
  • Deutsches Krebsforschungszentrum
  • Universitätsklinikum Heidelberg
  • National Institutes of Health

Zitieren

APA

Sill, M., Schrimpf, D., Patel, A., Sturm, D., Jäger, N., Sievers, P., Schweizer, L., Banan, R., Reuss, D., Suwala, A., Korshunov, A., Stichel, D., Wefers, A. K., Hau, A. C., Boldt, H., Harter, P. N., Abdullaev, Z., Benhamida, J., Teichmann, D., …, & Schüller, U. (2026). Advancing CNS tumor diagnostics with expanded DNA methylation-based classification. Cancer Cell, 44(2), 340-354.e2. https://doi.org/10.1016/j.ccell.2025.11.002

Vancouver

Sill M, Schrimpf D, Patel A, Sturm D, Jäger N, Sievers P, et al. Advancing CNS tumor diagnostics with expanded DNA methylation-based classification. Cancer Cell. 2026;44(2):340-354.e2. doi:10.1016/j.ccell.2025.11.002

BibTeX
@article{Sill2026,
  author = {Sill, Martin and Schrimpf, Daniel and Patel, Areeba and Sturm, Dominik and Jäger, Natalie and Sievers, Philipp and Schweizer, Leonille and Banan, Rouzbeh and Reuss, David and Suwala, Abigail and Korshunov, Andrey and Stichel, Damian and Wefers, Annika K and Hau, Ann-Christin and Boldt, Henning and Harter, Patrick N and Abdullaev, Zied and Benhamida, Jamal and Teichmann, Daniel and Koch, Arend and Hench, Jürgen and Frank, Stephan and Hasselblatt, Martin and Mansouri, Sheila and Díaz de Ståhl, Theresita and Serrano, Jonathan and Ecker, Jonas and Selt, Florian and Taylor, Michael and Ramaswamy, Vijay and Cavalli, Florence and Berghoff, Anna S and Bison, Brigitte and Blattner-Johnson, Mirjam and Buchhalter, Ivo and Buslei, Rolf and Calaminus, Gabriele and Dikow, Nicola and Dohmen, Hildegard and Euskirchen, Philipp and Fleischhack, Gudrun and Gajjar, Amar and Gerber, Nicolas U and Gessi, Marco and Gielen, Gerrit H and Gnekow, Astrid and Gottardo, Nicholas G and Haberler, Christine and Hamelmann, Stefan and Hans, Volkmar and Hansford, Jordan R and Hartmann, Christian and Heppner, Frank L and Driever, Pablo Hernaiz and von Hoff, Katja and Thomale, Ulrich W and Tippelt, Stephan and Frühwald, Michael C and Kramm, Christof M and Schüller, Ulrich},
  title = {Advancing CNS tumor diagnostics with expanded DNA methylation-based classification},
  journal = {Cancer Cell},
  year = {2026},
  volume = {44},
  number = {2},
  pages = {340--354.e2},
  doi = {10.1016/j.ccell.2025.11.002}
}
Kostenlos starten →